MADISON, Wis.--(BUSINESS WIRE)--The TomoTherapy® Hi·Art® cancer treatment system was featured in a presentation on capital equipment acquisition during the Association of Cancer Executives (ACE) annual meeting, Feb. 14-17, 2009, in Sarasota, Fla. The presentation was delivered by Terry McKay, founder and former president of ACE and current president and CEO of the West Michigan Cancer Center (WMCC), Kalamazoo, Mich. Ms. McKay detailed the reasons why WMCC chose the innovative radiation therapy solution developed by TomoTherapy Incorporated (NASDAQ: TOMO), and discussed how the Hi·Art system installation ranks among her 14 career linear accelerator (linac) purchases.
